Company intelligence / Profile preview

Baylx

Irvine, California, United Statesbaylxinc.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Baylx is a clinical-stage biopharmaceutical company developing novel stem cell therapeutics based on human umbilical cord tissue-derived mesenchymal stem cells. Its lead product BX-U001 has received US FDA IND clearance for rheumatoid arthritis and similar approval in China. The company also develops engineered MSCs for oncology and other indications such as IBD, liver cirrhosis, stroke, and COVID‑19. Their approach emphasizes the use of fresh rather than cryopreserved cells to maximize therapeutic potential. Early clinical results include regulatory clearances to initiate trials in RA and COVID‑19.[1][3]

Therapeutic areas: GastroenterologyRheumatologyOncologyNeurologyInfectious Diseases
Modalities: Human umbilical cord mesenchymal stem cells (hUC-MSC)Engineered hUC-MSCs (for malignant diseases)Stem cell therapy[1][4][5]
Industry: Biotech

Drug pipeline

4 assets

BX-U001

3 more assets in the full pipeline.

Request access →

Partnerships

Strategic partnership with Beijing Beilai Biosciences Co. Ltd.[3]

Beyond the preview

Go deeper on Baylx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baylx.

Explore the full profile